Pearl | American Lung Association

Location Select your location

Clinical Trials

Pearl

Institution:

Pearl Therapeutics

Type:

Multi-Center Trial

Purpose:

1. An orally inhaled (breathed through the mouth) combination of budesonide, glycopyrronium and formoterol fumarate inhalation aerosol metered dose inhaler. 2. An orally inhaled (breathed through the mouth) combination of glycopyrronium and formoterol fumarate. 3. An orally inhaled (breathed through the mouth) combination of budesonide and formoterol fumarate inhalation aerosol metered dose inhaler.

Dates:

January 8, 2016 - January 8, 2017

Disease:

COPD

Register:

http://www.activmedresearch.com/

Contact:

Karina Rosario
978-655-7155
krosario@activmedresearch.com

Ask An Expert

Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

Get help
We need your generous support

Make a difference by delivering research, education and advocacy to those impacted by lung disease.

What is LUNG FORCE?

LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

Get involved
Join the fight for healthy lungs and healthy air.
Donate Now.